AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cindolo model
Number of subjects: 515
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: Leibovich model
Number of subjects: 515
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: MSKCC model
Number of subjects: 515
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: IMDC model
Number of subjects: 515
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 515
Study 32623821 — intervention group
Group type: EXPERIMENTAL
Intervention: All models
Number of subjects: 515
Study 36434652 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective Structured Clinical Evaluation (OSCE)
Number of subjects: 86
Study 33307766 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training and aerobic exercise (TG)
Number of subjects: 63
Study 32965478 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable antipsychotics
Number of subjects: 368
Study 32965478 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 368
Study 35698001 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 0.2 μg/kg/min
Number of subjects: 172
Study 35698001 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 0.4 μg/kg/min
Number of subjects: 172
Study 35698001 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 172
Study 35698001 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil 0.2 μg/kg/min vs Normal saline
Number of subjects: 172
Study 32092065 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective-taking
Number of subjects: 195
Study 32092065 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 195
Study 32092065 — intervention group
Group type: COMPARATOR
Intervention: Stereotype-suppression
Number of subjects: 195
Study 32092065 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 195
Study 36243712 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg melatonin
Number of subjects: 99
Study 36243712 — intervention group
Group type: EXPERIMENTAL
Intervention: 600mg gabapentin
Number of subjects: 99
Study 36243712 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 99
Study 36243712 — intervention group
Group type: COMPARATOR
Intervention: Starch tablets (Control)
Number of subjects: 99
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Health utility values for all patients
Number of subjects: 320
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Health utility values for traders (those willing to lose part of their remaining life to avoid the disease)
Number of subjects: 320
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Health utility values for elderly patients
Number of subjects: 320
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Health utility values for patients living in rural areas
Number of subjects: 320
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical significance of socio-demographic factors
Number of subjects: 320
Study 34016041 — intervention group
Group type: EXPERIMENTAL
Intervention: Determinants of COVID-19 health utility value
Number of subjects: 320
Study 33370476 — intervention group
Group type: EXPERIMENTAL
Intervention: Gypsum cast records
Number of subjects: 10
Study 33370476 — intervention group
Group type: COMPARATOR
Intervention: Digital grayscale intra-oral scans
Number of subjects: 10
Study 32460633 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh attached wearable resistance (WR) of 2% body mass
Number of subjects: 14
Study 33781275 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified formula with n3-PUFA (n=42)
Number of subjects: 128
Study 33781275 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=86)
Number of subjects: 128
Study 35051141 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Number of subjects: 26
Study 35051141 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 26
Study 33059925 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage
Number of subjects: 60
Study 33059925 — intervention group
Group type: COMPARATOR
Intervention: Undrained group
Number of subjects: 60
Study 34167659 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal multichannel tDCS over bilateral TPJ
Number of subjects: 20
Study 34167659 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 32488923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime ultra rapid lispro (URLi)
Number of subjects: 1222
Study 32488923 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-meal ultra rapid lispro (URLi)
Number of subjects: 1222
Study 32488923 — intervention group
Group type: COMPARATOR
Intervention: Lispro
Number of subjects: 1222
Study 32488923 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 1222
Study 36267030 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 60
Study 36267030 — intervention group
Group type: COMPARATOR
Intervention: Anterior QLB
Number of subjects: 60
Study 33504040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Therapy Action Observation (MTAO)
Number of subjects: 0
Study 33504040 — intervention group
Group type: COMPARATOR
Intervention: Action Observation Therapy (AOT)
Number of subjects: 0
Study 32556550 — intervention group
Group type: EXPERIMENTAL
Intervention: Left upper lobectomy
Number of subjects: 1383
Study 32556550 — intervention group
Group type: COMPARATOR
Intervention: Other types of lobectomy
Number of subjects: 1383
Study 35270396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-pregnancy excess weight
Number of subjects: 68
Study 35270396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-pregnancy BMI
Number of subjects: 68
Study 33914296 — intervention group
Group type: EXPERIMENTAL
Intervention: EN3835 (collagenase)
Number of subjects: 15
Study 33914296 — intervention group
Group type: COMPARATOR
Intervention: Saline and methylene blue
Number of subjects: 15
Study 32881835 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (75 mg BID)
Number of subjects: 125
Study 35627877 — intervention group
Group type: EXPERIMENTAL
Intervention: First person perspective virtual training (experimental group)
Number of subjects: 52
Study 35627877 — intervention group
Group type: COMPARATOR
Intervention: Third person perspective (control group)
Number of subjects: 52
Study 35150524 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtalar mobilisation technique
Number of subjects: 52
Study 35150524 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic ultrasound (Control)
Number of subjects: 52
Study 32742515 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (0.5 cc, 5 mg)
Number of subjects: 88
Study 32742515 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg, given 30 minutes before surgery)
Number of subjects: 88
Study 32742515 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (25 μg)
Number of subjects: 88
Study 32742515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (four capsules with a hint of lemon)
Number of subjects: 88
Study 36124709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - hospital-based lifestyle course and primary care follow-up
Number of subjects: 601
Study 36124709 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 601
Study 36124709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG)
Number of subjects: 601
Study 36277011 — intervention group
Group type: EXPERIMENTAL
Intervention: Metagenomic next-generation sequencing (mNGS)
Number of subjects: 138
Study 36277011 — intervention group
Group type: COMPARATOR
Intervention: General bacterial and fungal culture
Number of subjects: 138
Study 34905431 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 579
Study 34905431 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy (HL) and Knowledge
Number of subjects: 579
Study 35683427 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (600 mL divided into two doses administered on days 1 and 2)
Number of subjects: 54
Study 35683427 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (Control group)
Number of subjects: 54
Study 33483197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 73
Study 33483197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 32873093 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning BTA injections
Number of subjects: 61
Study 32873093 — intervention group
Group type: COMPARATOR
Intervention: Afternoon BTA injections
Number of subjects: 61
Study 35028684 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific contrast enhancement optimizer simulation software (p-COP)
Number of subjects: 102
Study 35028684 — intervention group
Group type: COMPARATOR
Intervention: Conventional contrast material (CM) injection protocol based on body weight
Number of subjects: 102
Study 34499111 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye examinations and eyeglasses (intervention group, cohort 1)
Number of subjects: 2304
Study 34499111 — intervention group
Group type: COMPARATOR
Intervention: Control groups (cohorts 2 and 3)
Number of subjects: 2304
Study 34982319 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Addenbrooke's Cognitive Examination (MACE)
Number of subjects: 231
Study 34982319 — intervention group
Group type: COMPARATOR
Intervention: International HIV Dementia Scale (IHDS)
Number of subjects: 231
Study 34406695 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation)
Number of subjects: 77
Study 34406695 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 77
Study 32820647 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608
Study 32820647 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 608
Study 35298191 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths-based family program
Number of subjects: 234
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 500 μM
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 5 mM
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 500 μM in RNCMs
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 5 mM in RNCMs
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) 5 mM
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with NR 0.35%
Number of subjects: 0
Study 32209328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with NR 1.0%
Number of subjects: 0
Study 34887466 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking liquid food after tasting
Number of subjects: 11
Study 34887466 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding chewing while tasting
Number of subjects: 11
Study 34887466 — intervention group
Group type: COMPARATOR
Intervention: Drinking liquid food normally
Number of subjects: 11
Study 34198100 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed-forward artificial neural network (ANN) model
Number of subjects: 1412
Study 32068562 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 31
Study 32068562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 35460868 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery (VD)
Number of subjects: 462
Study 35460868 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor duration
Number of subjects: 462
Study 33242299 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Resistance Training (DRT)
Number of subjects: 193
Study 33242299 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric Resistance Training (IRT)
Number of subjects: 193
Study 33242299 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 193
Study 35727582 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvesting (EVH)
Number of subjects: 1150
Study 35727582 — intervention group
Group type: COMPARATOR
Intervention: Open vein harvesting (OVH)
Number of subjects: 1150
Study 34607088 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 0
Study 34607088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32507157 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise followed by resistance exercise (AR)
Number of subjects: 15
Study 32507157 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise followed by combined aerobic exercise (RA)
Number of subjects: 15
Study 35523495 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal electrical stimulation (TdES) with skin electrodes
Number of subjects: 50
Study 35523495 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 50
Study 33962185 — intervention group
Group type: EXPERIMENTAL
Intervention: Theme game-based teaching
Number of subjects: 104
Study 33962185 — intervention group
Group type: COMPARATOR
Intervention: Multi-station disaster simulation
Number of subjects: 104
Study 34628013 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary palliative care (PC)
Number of subjects: 150
Study 34628013 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 150
Study 32332490 — intervention group
Group type: EXPERIMENTAL
Intervention: PHAB accreditation
Number of subjects: 1329
Study 32332490 — intervention group
Group type: COMPARATOR
Intervention: PHAB-accredited states
Number of subjects: 1329
Study 33466200 — intervention group
Group type: EXPERIMENTAL
Intervention: ABRS granules
Number of subjects: 312
Study 33466200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 32124469 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-flow portable oxygen concentrator (cPOC)
Number of subjects: 26
Study 32124469 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-flow portable oxygen concentrator (pPOC)
Number of subjects: 26
Study 32124469 — intervention group
Group type: COMPARATOR
Intervention: Control group (alternative POC)
Number of subjects: 26
Study 33580809 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT) daily from inclusion to the day of surgery
Number of subjects: 159
Study 33580809 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PFMT)
Number of subjects: 159
Study 35166373 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paracetamol (0.6 ml.kg‐1, 24 mg.ml‐1 concentration)
Number of subjects: 97
Study 35166373 — intervention group
Group type: COMPARATOR
Intervention: Water alone (3.6 ml.kg‐1)
Number of subjects: 97
Study 33710926 — intervention group
Group type: COMPARATOR
Intervention: Inflammatory condition (INF)
Number of subjects: 16
Study 33710926 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 16
Study 33710926 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (CON and INF)
Number of subjects: 16
Study 36200545 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous treatment (35.0% in 2020 vs. 25.9% in 2019; p < 0.0001)
Number of subjects: 2498
Study 36200545 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical referral (3.7% in 2020 vs. 4.9% in 2019; p = 0.0001)
Number of subjects: 2498
Study 36200545 — intervention group
Group type: EXPERIMENTAL
Intervention: New York Heart Association (NYHA) class IV for heart failure
Number of subjects: 2498
Study 36200545 — intervention group
Group type: COMPARATOR
Intervention: Hospitalization outcomes
Number of subjects: 2498
Study 33895103 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 242
Study 33895103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 32795341 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilars to etanercept, infliximab, and adalimumab (SB4, SB2, SB5)
Number of subjects: 1371
Study 32795341 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline predictors (SJC28, CRP, PhGA)
Number of subjects: 1371
Study 35145311 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine
Number of subjects: 832
Study 35145311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 832
Study 34857215 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drink with Lactobacillus strains for 8 weeks
Number of subjects: 50
Study 33261932 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray combined with a new oral antidepressant (AD)
Number of subjects: 0
Study 33261932 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with a new oral antidepressant (AD)
Number of subjects: 0
Study 32456999 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional attire
Number of subjects: 123
Study 32456999 — intervention group
Group type: COMPARATOR
Intervention: Scrubs
Number of subjects: 123
Study 35858589 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib plus TQB2450
Number of subjects: 34
Study 33780173 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 66
Study 33780173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 32838762 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video on weight-related conversations
Number of subjects: 57
Study 36277008 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiyanping
Number of subjects: 86
Study 36277008 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 86
Study 33721974 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based lifestyle modification (LSM) program
Number of subjects: 415
Study 33721974 — intervention group
Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 415
Study 32384461 — intervention group
Group type: EXPERIMENTAL
Intervention: NKCE
Number of subjects: 90
Study 32384461 — intervention group
Group type: EXPERIMENTAL
Intervention: NK
Number of subjects: 90
Study 32384461 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 36011556 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent social support intervention (Exercise Methods and Wellness Knowledge Guide leaflet three times a week)
Number of subjects: 366
Study 36011556 — intervention group
Group type: COMPARATOR
Intervention: Control group (no changes required)
Number of subjects: 366
Study 36011556 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent social support intervention
Number of subjects: 366
Study 32199245 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective-shifting
Number of subjects: 56
Study 32199245 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive sentences
Number of subjects: 56
Study 35094649 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercise plus dry needling
Number of subjects: 37
Study 35094649 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise only
Number of subjects: 37
Study 33789133 — intervention group
Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 76
Study 33789133 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 76
Study 33275751 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation at the time of measles vaccination
Number of subjects: 0
Study 33275751 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 35882525 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sterile gloves and dressings
Number of subjects: 1480
Study 35882525 — intervention group
Group type: COMPARATOR
Intervention: Sterile gloves, dressings and drapes
Number of subjects: 1480
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal/Filtek Z350XT (SBU)
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective enamel conditioning (E-SBU)
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cements (RMGIC)
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylenediaminetetraacetic acid pretreatment (EDTA; E-RMGIC)
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: SBU
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: SE-SBU
Number of subjects: 50
Study 34705986 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study 33103448 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 28
Study 33259829 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein breakfast (HP)
Number of subjects: 27
Study 33259829 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate breakfast (HC)
Number of subjects: 27
Study 33259829 — intervention group
Group type: COMPARATOR
Intervention: Curtailed sleep (CS)
Number of subjects: 27
Study 32756846 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical weeding treatments
Number of subjects: 50
Study 32756846 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagrammatic scoring scale
Number of subjects: 50
Study 35074278 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intervention to increase teacher scheduling of physical activity
Number of subjects: 2485
Study 35074278 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 2485
Study 35074278 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intervention
Number of subjects: 2485
Study 32394019 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 559
Study 32394019 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 559
Study 32394019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 559